Acme United Corporation reported first‑quarter 2026 results that saw net sales climb 14% to $52.3 million, driven by a 6% rise in comparable sales and the addition of $19 million in revenue from the January acquisition of My Medic. The company’s gross margin improved to 39.7% from 39.0% a year earlier, reflecting a modest pricing advantage and a favorable mix shift toward higher‑margin U.S. and Canadian markets.
Net income fell 40% to $1.0 million, or $0.24 per diluted share, a miss of $0.24 against the consensus estimate of $0.4848. Management attributed the earnings shortfall to higher cost of sales, tariff‑related expenses from inventory subject to 2025 duties, one‑time investments in quality‑assurance protocols at the Med‑Nap facility, and rising employee healthcare costs. The company expects the My Medic business to contribute most of its profitability in the fourth quarter, offsetting the current quarter’s margin pressure.
Revenue beat analyst expectations by $4.2 million, surpassing the consensus estimate of $48.1 million. The beat was largely driven by strong demand in the U.S. and Canadian markets, where sales grew 14% year‑over‑year, while European sales increased 12%. The acquisition of My Medic added a new product line that has already generated $19 million in sales, reinforcing Acme United’s position in the tactical and emergency response segment.
The market reacted cautiously but positively, with the stock gaining about 5.4% in pre‑market trading. Investors focused on the revenue beat and the strategic value of the My Medic acquisition, while the EPS miss highlighted ongoing cost pressures from tariffs and investment outlays. Analysts noted that the company’s gross margin improvement suggests pricing resilience, but the net income decline signals that cost control remains a priority for the coming quarters.
Management reiterated its confidence in the company’s long‑term growth trajectory, emphasizing that the investments in quality assurance and the integration of My Medic are expected to generate incremental profitability in the near term. The company’s bank debt less cash rose to $38.6 million from $27.2 million a year earlier, reflecting financing for acquisitions and capital expenditures. Despite the earnings miss, Acme United’s revenue growth and margin expansion provide a foundation for future profitability as the company continues to scale its operations.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.